|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||2.3400 - 2.4700|
|52 Week Range||1.6070 - 7.8940|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
It’s no question that the marijuana industry is a budding space. The industry saw $10.9 billion in sales last year, not including sales that occurred illegally. Not to mention analysts predict this figure could jump by anywhere between $50 billion to $200 billion over the next ten years. However, somewhere along the way things went awry for cannabis stocks. A few have actually seen growth slow with some being bogged down by supply-side issues and tax concerns in the U.S. That’s not to say that these stocks won’t see upside again, but investors will have to be patient and pay close attention to determine whether or not they can recover. Analysts from Wall Street’s top firms highlight 3 beaten-down cannabis stocks to watch. Let's take a closer look: Canopy Growth Corporation (CGC)Many investors are wondering what happened to Canopy Growth. The prominent medical cannabis company has taken a beating in its last two quarters, with growth becoming stagnant. In its most recent quarter, CGC reported disappointing Q1 results that didn’t just miss but rather failed to come close to consensus estimates. While the company posted quarterly net revenue of CA$90.5 million, up by more than 3x from the year-ago quarter, investors were not impressed as this result was well below the Street’s CA$109 million estimate. More bad news came when CGC reported its net loss widened to CA$1.3 million from CA$91,000 in the prior-year quarter. Management attributes the loss to a drastic drop in cannabis oil and softgel sales, plunging to CA$0.2 million from CA$36.5 million in Q4. While some have placed the blame on channel stuffing or filling distribution channels with more product than is needed, others have pointed to new competitors that have zeroed in on CGC’s market share.CIBC analyst John Zamparo believes that the latter is the case with Canopy. “We believe the decline amounts to an unsustainable market share from the onset of adult-use legalization, with competitors now having improved their offering,” he explained. (To watch Zamparo's track record, click here) The analyst does note that its backing from Constellation Brands (STZ) as well as its 15 upcoming clinical trials and 270 patents lends itself to strong long-term growth prospects. “We believe investors will need to show patience to allow Canopy to build its international presence as clinical trials and patents take time to play out and eventually give Canopy Growth an advantage versus peers,” Zamparo added. As a result, Zamparo reiterated his Outperform rating on CGC but did drop the price target from $80 to $50. All in all, the rest of the Street is cautiously optimistic about CGC. With 9 Buy ratings vs 6 Holds received over the last three months, the consensus among analysts is that this cannabis stock is a ‘Moderate Buy’. Its $44 average price target suggests 57% upside potential. (See CGC’s price targets and analyst ratings on TipRanks) Tilray Inc. (TLRY)The second cannabis stock on our list, like CGC, didn’t exhibit the level of growth investors wanted to see. While Tilray’s second quarter revenue gained year-over-year, its losses more than doubled from the year-ago quarter. The company has failed to generate a profit in the year since its IPO, with management warning investors that this won’t change anytime soon. Investors are especially troubled by TLRY’s international sales. It trails behind its competitors in this segment of the business and has shown only small sequential improvement. That being said, TLRY has made efforts to expand its reach in the Portugal market with the GMP certification of its facility in the country. TLRY is also expanding its access to the domestic market by opening more retail locations in key Canadian provinces, including Ontario. Additionally, the cannabis company stands to benefit from the launch of the Canadian cannabis derivatives market in October. Jefferies analyst Ryan Tomkins argues that while TLRY hasn’t quite achieved a turnaround yet, the company is taking steps in the right direction. “Continued recreational revenue increases and expected international medical sales pickup obvious positives, but still reasons for caution in our view,” the analyst explained. The analyst adds on a positive note that management stated oversupply was not pressing as they once thought, and quality supply was scarce, which led to investments in expanding their own facilities. It was also able to launch a new broad spectrum CBD product under the Manitoba Harvest brand in the U.S. As all of these factors have not quelled his concerns, Tomkins reiterated his Hold rating and $57 price target on TLRY stock.All in all, the rest of the Street mirrors the analyst’s cautious sentiment, with TipRanks analytics showcasing TLRY as a Hold. (See TLRY’s price targets and analyst ratings on TipRanks) The Green Organic Dutchman Holdings (TGOD)Lackluster second quarter results have put a dark cloud over this cannabis stock. On August 13, TGOD reported that its sales for the quarter totaled CA$2.8 million, falling well below the CA$4.6 million consensus estimate. It didn’t help that its cash dropped from CA$214 million at the beginning of 2019 to CA$69 million in Q2. That being said, one analyst believes that concerns regarding sales and cash flow have been blown out of proportion. Tomkins, who also covers TGOD, points out that its sales only include revenue generated from the HemPoland segment of its business. Once the company’s new Grower’s Circle launch extends beyond its pilot program, Tomkins thinks sales should get a boost. “Any disappointment is misplaced, in our view. We see sales strongly picking up from here and with costs under control, we think the company is well placed to hit its target of turning a profit by the end of Q1 2020,” the Jefferies analyst added. As a result, Tomkins reiterated his Buy rating and CA$6.50 price target.TGOD announced it had received a purchase order from Ontario as well as new supply and distribution agreements with the provincial boards Alberta Cannabis and BC Cannabis stores, which management hopes will bolster sales. While these positive developments have led some to believe that the tide is turning for the marijuana stock, not all analysts are convinced TGOD has pulled off a turnaround. (See TGOD’s price targets and analyst ratings on TipRanks)
The next five days will still be full of news surrounding the cannabis space. We have compiled a list of main things that cannabis investors should be keeping an eye on this week. Ontario Lottery And New ...
TORONTO, Aug. 16, 2019 /PRNewswire/ - The Green Organic Dutchman Holdings Ltd. (the "Company" or "TGOD") (TGOD.TO) (TGODF), a leading producer of premium certified organic cannabis, is pleased to announce that it has completed its inaugural shipment to the Ontario Cannabis Store, marking the Company's entrance into Canada's recreational market. Ontario consumers will soon be able to experience TGOD's acclaimed Unite Organic dried flower, the Company's high THC signature strain, which will be available on www.ocs.ca as well as at select retail locations across the province.
CEO Brian Athaide says the company has received "overwhelmingly positive" feedback for its premium certified organic cannabis products.
Canadian cannabis producer Green Organic Dutchman Holdings Ltd (OTC: TGODF) reported its financial results for the second quarter, which included a revenue growth of 20% sequentially. Benzinga's Cannabis Capital Conference heads to Detroit on Aug. 15 — click here to learn more! Earlier this month, Green Organic Dutchman said it had applied to have its stock listed on the NASDAQ market.
TORONTO, Aug. 13, 2019 /PRNewswire/ - The Green Organic Dutchman Holdings Ltd. (the "Company" or "TGOD") (TGOD.TO) (TGODF) is pleased to report its financial and operational results for the three and six months ended June 30, 2019. In Canada, the Company launched its pilot "Grower's Circle", which included sales to a small number of medical patients to test the market and the Company's distribution capabilities. The Company launched two new products in Q2 and expects to start a similar pilot in the Ontario recreational market during Q3-2019.
for elections in October, after his surprise primary electoral defeat prompted a currency plunge and threatened the country’s ability to avoid a debt default. by an unexpectedly large margin, as his Peronist rival Alberto Fernández won 47 per cent of the vote. “Every election is a message, and we understand it,” a defiant Mr Macri told reporters on Monday.
[Editor's note: This story will be updated each week with new stocks and analysis. Please check back often for Mark's latest take on marijuana penny stocks.]Every investor has dreams of investing a couple thousand dollars into the penny stock company that with become the next Amazon (NASDAQ:AMZN) or Microsoft (NASDAQ:MSFT). Marijuana penny stocks are especially appealing to some of these investors because they understand how much potential this industry has.But you need to be very careful investing in this highly risky sector of the market. Many of these companies will not survive. There is a reason why they are trading as penny stocks.InvestorPlace - Stock Market News, Stock Advice & Trading TipsA few weeks ago I was at the local farmers market and I had an interesting conversation with a farmer. I mentioned that I thought the vegetables that come from the market are significantly better than those that come from the grocery store. He said it was because the vegetables were grown with natural sunlight, while the ones grown in the grocery store were grown indoors or in greenhouses.That made me think about if the same thing applies to growing cannabis. I have done some research, and sure enough there is a trend towards outdoor growing. Investors are starting to understand that in many cases, the cost and quality advantages of growing outside exceed any advantages that can be gained by indoor or greenhouse growing. * 7 Stocks Under $7 to Invest in Now A few of the companies that I have included are in the cannabis outside growing (aka farming) business. In addition, I have also included a few stocks with cool technical patterns.These are not buy recommendations. I just want to give you some insight that may help your investments. Marijuana Penny Stocks: 48North Cannabis (NRTH)48North Cannabis (TSE:NRTH) produces and sells medical cannabis. This a company that I am looking at as a potential investment into outdoor growing. It recently announced that it completed planting its 100-acre outdoor growing facility.Most of the larger growers such as Tilray (NASDAQ:TLRY), Aphria (NYSE:APHA) and Canopy Growth (NYSE:CGC) primarily grow their cannabis either in indoor growing facilities or greenhouses.As mentioned above, there are some advantages to indoor growing. These include things such as better security and the ability to grow yearlong in cold climates. However, some investors are starting to understand that the cost benefits of outdoor growing exceed any benefits that are derived from the other methods.In addition, similar to what the farmer told me, some marijuana consumers believe that cannabis that is grown under natural sunlight is better than that grown inside. If the big companies that are growing indoors do not address this dynamic, it could provide a great opportunity for companies like 48North. Emerald Health Therapeutics (EMHTF)Emerald Health Therapeutics (OTCMKTS:EMHTF) is a Canadian producer of cannabis products.Like 48North, the management of this company is putting some focus on outside growing. It recently announced that it had received it's outdoor cultivation license from Health Canada. The larger Canadian indoor growers have used their influence to slow down the issuance of outdoor licenses. However, as the industry is evolving, they are losing their ability to continue to do so.There are two other things happening here that may be bullish for EMHTF stock. First, it is holding above support around the $1.50 level. This level was where the lows were in December. * 8 Dividend Aristocrat Stocks to Buy Now No Matter What In addition, the company announced the appointment of a new CEO. Riaz Bandali has over 25 years of experience. The appointment of this veteran to run the company could give it an advantage over its competitors that are being managed by those with less experience. KushCo Holdings (KSHB)KushCo Holdings (OTCMKTS:KSHB) produces and sells packaging products for companies that are in the marijuana industry.KSHB stock is approaching the $4.30 level. In June and July, it found support there and sub sequentially rallied. At the end of July, the stock was oversold. If it gets to $4.30 again while being oversold, there is a chance it will rally again.When stocks get to important support levels and become oversold, they tend to rally. If they get to important support and spend time consolidating, they tend to eventually break the level and go lower.What does oversold mean? It is a measurement of momentum. It is where the price is today versus where it was X many days ago. When this number reaches an extreme on the downside, it is considered oversold.For example, statistics tell us the 95% of all trading should be within two standard deviations of the mean. If a stock is more than two standard deviations below the mean, it would be considered oversold. Cannabis Sativa (CBDS)Cannabis Sativa (OTCMKTS:CBDS) researches and develops specialized natural cannabis-related products.Last August, CBDS stock found support around the $2 level. After rallying and then trending lower, it once again found support at this level at the end of April and throughout May.Then the level was broken, and the stock traded lower before recovering. Now $2 is a resistance level. How does this happen? How does a level that was formally support become a resistance level? * 5 Cheap Stocks to Buy Now That the Fed Cut Rates Consider the following. The people who bought the stock at $2 are losing money once it trades lower. They tell themselves that if the stock recovers and gets back to $2, they will sell it so they can get out break even. (Sound familiar?) This concentration of sellers is what creates a resistance level. Green Organic Dutchman Holdings (TGODF)Green Organic Dutchman Holdings (OTCMKTS:TGODF) provides medical cannabis solutions. The downtrend that began in TGODF stock in April seems to have broken.Some people do not understand how profitable the ability to draw and understand trendlines can be. It is obviously an art and not a science, but with some practice and an understanding it will help your trading or investing.In financial markets, prices are always doing one of three things -- going up, going down, or staying the same. If they are going up, the forces of demand are in control of the market. When prices are going lower, the forces of supply are in control. When prices are staying the same, the forces are equal. A popularly drawn trendline should simply be an illustration of these dynamics.We can see here that from a longer-term perspective, the forces of supply have been in control of this market. The downtrend line that I drew has been broken. This could mean that the forces of demand are about to take over and drive the price higher. CannTrust Holdings (CTST)CannTrust Holdings (NYSE:CTST) produces and sells medical cannabis.This company is now known affectionately as Can't Trust. This is because it has recently been accused of growing cannabis in illegal grow rooms that were not licensed. Since then CTST stock has dropped from $5 to $2.Senior management seems to have been well aware that this illicit activity was occurring. We know this because they discussed it in emails which are now in possession of the authorities. When will people ever learn? If you wouldn't want your grandmother to read it, do not put it in an email.My guess is that there are other companies that are engaged in similar illegal activity, and we will soon be hearing about others. * 10 Stocks to Buy on the Trade War Dip Over the past three weeks the stock has found support around the $2 level. Despite this, I can't trust CannTrust to be a safe investment. Until we know more details, I would stay away. CGrowth Capital (CGRA)CGrowth Capital (OTCMKTS:CGRA) is a holding company that is engaged in exploration, mining and commodities.This stock illustrates a valuable lesson. Every stock has a bid and an offer. The bid is the highest price someone will pay for a stock. The offer is the lowest price that someone is willing to sell it at.Now suppose a stocks bid is 1 cent and the offer is 2 cents. If someone sells it, the last trade will be 1 cent. Then suppose 10 minutes later someone else buys it. Now the last trade is 2 cents. The stock price has doubled but it hasn't really moved!CGRA stock illustrates a similar dynamic. Over the past week, the price has nearly doubled in value. It has gone from 45 thousandths to 70 thousandths of 1 cent. Could you have made money on this move? Absolutely not. Commission costs and market impact would have made it impossible. The stock has almost doubled in price but the shareholders haven't benefited.At the time of this writing Mark Putrino did not hold any positions in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Large-Cap Stocks to Sell Right Now * 7 Stocks Under $7 to Invest in Now * 7 Marijuana Stocks With Critical Levels to Watch The post 7 Marijuana Penny Stocks to Consider for Those Who Can Handle Risk appeared first on InvestorPlace.
The company also addresses the legalized recreational adult-use market in Canada, sells organic hemp CBD oil and distributes premium hemp CBD oil products across Europe. The company said it will continue listing its stock on Canada's TSX exchange under the ticker "TGOD" if it is approved to list on the Nasdaq under the same symbol.
TORONTO , Aug. 6, 2019 /PRNewswire/ - The Green Organic Dutchman Holdings Ltd. ("TGOD" or the "Company") (TSX: TGOD) (US: TGODF) announced today that the Company expects to release ...
TORONTO, Aug 2, 2019 /PRNewswire/ - The Green Organic Dutchman Holdings Ltd. (the "Company" or "TGOD") (TGOD.TO) (TGODF) is pleased to announce that it has successfully renewed its Health Canada licences for the Company's Ancaster, Ontario facility until August 2022. As per the Cannabis Regulations, these licences authorize TGOD to cultivate, process and sell cannabis from its Ancaster site. "From day one, the entire team at TGOD placed a strong focus on ethics and compliance.
The Green Organic Dutchman's Valleyfield Facility Receives Organic Certification from Internationally Recognized Pro-Cert
L'installation de Valleyfield de TGOD reçoit la certification biologique de Pro-Cert, une agence de certification reconnue internationalement
TORONTO , June 20, 2019 /CNW/ - The Green Organic Dutchman Holdings Ltd. (the "Company" or "TGOD") (TGOD.TO) (TGODF) is pleased to announce its expansion into the global organic hemp CBD market with the launch of its Global Strategic Hemp Division. This new division will leverage TGOD's solid expertise in the European hemp CBD market to fuel growth and accelerate the development and commercialization of new products across its network of international partners.
Shares of Neptune Wellness Solutions Inc. rallied Wednesday, after the Canada-based company announced a second 3-year extraction agreement with a cannabis company in a week.
Shares of Neptune Wellness Solutions Inc. shot up 11% toward a record high in premarket trade Wednesday, after the Canada-based extraction and purification company announced a 3-year agreement with cannabis company Green Organic Dutchman Holdings Ltd. . Under terms of the agreement, Green Organic will supply more than 230,000 kilograms of cannabis and hemp biomass to Neptune, which will extract and purify cannabinoids and terpenes, to be transformed into organic finished products. The first shipment of biomass is expected to be received in September 2019. The deal comes less than a week after Neptune announced a 3-year extraction and purification agreement with cannabis company Tilray Inc. , that sent Neptune's stock to a record close on Friday. Neptune's stock has rallied 39.3% over the past three months while Green Organic shares have shed 20.5%, the ETFMG Alternative Harvest ETF has lost 11.0% and the S&P 500 has gained 3.4%.